Screening assays of new anti-tuberculosis drugs (2002)
- Authors:
- USP affiliated author: SILVA, CELIO LOPES - FMRP
- School: FMRP
- Subjects: TUBERCULOSE (TRATAMENTO); BIOQUÍMICA
- Language: Inglês
- Imprenta:
- Publisher: REDE-TB
- Place of publication: Rio de Janeiro
- Date published: 2002
- Conference title: Workshop da Rede Brasileira de Pesquisa em Tuberculose
-
ABNT
DE SOUZA, A. O.; SILVA, Célio Lopes. Screening assays of new anti-tuberculosis drugs. Anais.. Rio de Janeiro: REDE-TB, 2002. -
APA
De Souza, A. O., & Silva, C. L. (2002). Screening assays of new anti-tuberculosis drugs. In . Rio de Janeiro: REDE-TB. -
NLM
De Souza AO, Silva CL. Screening assays of new anti-tuberculosis drugs. 2002 ; -
Vancouver
De Souza AO, Silva CL. Screening assays of new anti-tuberculosis drugs. 2002 ; - Cell wall components of ac actinomycetis involved in the pathogeny of actinomicotic mycetona
- Cord factor is associated with the maintenance of chronic inflammatory reaction caused by mycobacteria
- Mouse toxicity induced by lipids and cell wall isolated from actinomycetis
- Echocardiographic assessment of muscarinic receptor plasmid DNA immunized mice
- DNA based therapy against tuberculosis
- Adjuvant effect of immunostimulants and HSP65 protein encapsulated in microspheres: production of IL-12 by J774 cells
- Induction of immune response by genetic immunization (pVax-hsp65) in a murine model of atherosclerosis
- Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage
- Downmodulation of peripheral MOG-specific immunity by pVAXhsp65 treatment during EAE does not reach the CNS
- A single dose of a DNA vaccine encoding Apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against Tuberculosis in Mycobacterium bovis BCG-primed mice
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
